Company intelligence / Profile preview

Paxman

Huddersfield, West Yorkshire, United Kingdompaxmanscalpcooling.com ↗

Ownership: Private
Development stage: Commercial

Overview

Paxman's clinically proven scalp cooling system has helped over 100,000 cancer patients worldwide retain their hair during chemotherapy. The system is used in multiple continents with over 3,500 delivered systems active in over 35 markets. Recent clinical studies show efficacy varies based on chemotherapy regimens, with taxane-based regimens showing the highest rates of hair retention.

Therapeutic areas: OncologyNeurology
Modalities: Medical cooling devices
Industry: Therapeutic Medical Devices

Partnerships

National University Singapore (for CIPN research)University of Huddersfield (R&D center)

Beyond the preview

Go deeper on Paxman.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paxman.

Explore the full profile